Novvi’s biobased alpha-olefin-sulfonate technology is being commercialized as CalCare AOS through an exclusive partnership for North American household, industrial/institutional, and personal-care markets. The source states that the surfactants are intended to match traditional AOS performance while adding biobased content, with commercial quantities planned from the second half of 2025.